Carbon Nanostructure-Based Materials: A Novel Tool for Detection of Alzheimer’s Disease

  • Mohammad AshfaqEmail author
  • Neetu Talreja
  • Divya Chuahan
  • Werayut Srituravanich


Alzheimer’s disease is one of the most common forms of dementia and is an overwhelming neurodegenerative disease. Usually, this neurological condition is categorized by a loss of cognitive functions and recognized pathophysiological hallmarks in the brain such as accumulation of extracellular (amyloid-β (Aβ) peptide) and intracellular (neurofibrillar tangles of hyperphosphorylated τ protein) protein. Presently, a huge number (approximately 35 million) of people are affected by this form of dementia and neurodegenerative disease. The situation becomes more dangerous and will lead to social burden in the near future. Therefore, there is a need to develop effective therapy and early diagnostic approaches. In this context, biosensor has become an indispensable tool in biomarker sensing, in which sensor electrode materials play critical roles in accurate and selective sensing. Carbon nanostructure-based materials have the potential ability for biosensor platform because of their excellent mechanical, electronic, optical, and easy functionalization ability. Herein, we discuss the various carbon nanostructure-based materials, biomarkers of Alzheimer’s disease, carbon nanostructured material-based biosensor, and future prospects in the detection of Alzheimer’s disease.


Alzheimer’s disease Nanomaterials Biosensor Biomarkers Neurological disease 



The authors acknowledge support from Chulalongkorn University through Chulalongkorn Academic Advancement into its Second Century Project (Small Medical Device) and support from NPDF, SERB, Department of Science and Technology, New Delhi, India, in the form of a research grant (PDF/2016/003602).


  1. Afreen S, Omar RA, Talreja N, Chauhan D, Ashfaq M (2018) Carbon-based nanostructured materials for energy and environmental remediation applications. In: Prasad R, Aranda E (eds) Approaches in bioremediation: the new era of environmental microbiology and Nanobiotechnology. Springer, Cham, pp 369–392. Scholar
  2. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH (2011a) The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7(3):270–279. Scholar
  3. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH (2011b) The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7(3):270–279. Scholar
  4. Alves L, Correia ASA, Miguel R, Alegria P, Bugalho P (2012) Alzheimer’s disease: a clinical practice-oriented review. Front Neurol 3:63–63. Scholar
  5. Anoop A, Singh PK, Jacob RS, Maji SK (2010) CSF biomarkers for Alzheimer’s disease diagnosis. Int J Alzheimers Dis 2010:606802. Scholar
  6. Ashfaq M, Singh S, Sharma A, Verma N (2013) Cytotoxic evaluation of the hierarchical web of carbon micronanofibers. Ind Eng Chem Res 52(12):4672–4682. Scholar
  7. Ashfaq M, Khan S, Verma N (2014) Synthesis of PVA-CAP-based biomaterial in situ dispersed with Cu nanoparticles and carbon micro-nanofibers for antibiotic drug delivery applications. Biochem Eng J 90:79–89. Scholar
  8. Ashfaq M, Verma N, Khan S (2016) Copper/zinc bimetal nanoparticles-dispersed carbon nanofibers: a novel potential antibiotic material. Mater Sci Eng C 59:938–947. Scholar
  9. Ashfaq M, Verma N, Khan S (2017a) Carbon nanofibers as a micronutrient carrier in plants: efficient translocation and controlled release of Cu nanoparticles. Environ Sci Nano 4(1):138–148. Scholar
  10. Ashfaq M, Verma N, Khan S (2017b) Highly effective Cu/Zn-carbon micro/nanofiber-polymer nanocomposite-based wound dressing biomaterial against the P. aeruginosa multi- and extensively drug-resistant strains. Mater Sci Eng C 77:630–641. Scholar
  11. Ashfaq M, Verma N, Khan S (2018) Novel polymeric composite grafted with metal nanoparticle-dispersed CNFs as a chemiresistive non-destructive fruit sensor material. Mater Chem Phys 217:216–227. Scholar
  12. Azimzadeh M, Nasirizadeh N, Rahaie M, Naderi-Manesh H (2017) Early detection of Alzheimer’s disease using a biosensor based on electrochemically-reduced graphene oxide and gold nanowires for the quantification of serum microRNA-137. RSC Adv 7(88):55709–55719. Scholar
  13. Barber RC (2010) Biomarkers for early detection of Alzheimer disease. J Am Osteopath Assoc 110(9_suppl_8):S10–S15PubMedGoogle Scholar
  14. Bauer J, Strauss S, Schreiter-Gasser U, Ganter U, Schlegel P, Witt I, Yolk B, Berger M (1991) Interleukin-6 and α-2-macroglobulin indicate an acute-phase state in Alzheimer’s disease cortices. FEBS Lett 285(1):111–114. Scholar
  15. Bhadauriya P, Mamtani H, Ashfaq M, Raghav A, Teotia AK, Kumar A, Verma N (2018) Synthesis of yeast-immobilized and copper nanoparticle-dispersed carbon Nanofiber-based diabetic wound dressing material: simultaneous control of glucose and bacterial infections. ACS Appl Bio Mater 1(2):246–258. Scholar
  16. Bjerke M, Engelborghs S (2018) Cerebrospinal fluid biomarkers for early and differential Alzheimer’s disease diagnosis. J Alzheimers Dis 62(3):1199–1209. Scholar
  17. Blasko I, Lederer W, Oberbauer H, Walch T, Kemmler G, Hinterhuber H, Marksteiner J, Humpel C (2006) Measurement of thirteen biological markers in CSF of patients with Alzheimer’s disease and other dementias. Dement Geriatr Cogn Disord 21(1):9–15. Scholar
  18. Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM (2007) Forecasting the global burden of Alzheimer’s disease. Alzheimers Dement 3(3):186–191. Scholar
  19. Cárdenas-Aguayo MC, Gómez-Virgilio L, DeRosa S, Meraz-Ríos MA (2014) The role of tau oligomers in the onset of Alzheimer’s disease neuropathology. ACS Chem Neurosci 5(12):1178–1191. Scholar
  20. Choi EJ, Bang H, Im JH, Chung SJ, Lee J-H (2005) A case of biopsy-proven early-onset Alzheimer’s disease with Hemiparkinsonism. J Clin Neurol (Seoul, Korea) 1(1):97–100. Scholar
  21. Chowdhury A, Kunjiappan S, Panneerselvam T, Somasundaram B, Bhattacharjee C (2017) Nanotechnology and nanocarrier-based approaches on treatment of degenerative diseases. Int Nano Lett 7(2):91–122. Scholar
  22. Congur G, Eksin E, Erdem A (2015) Impedimetric detection of microRNA at graphene oxide modified sensors. Electrochimica Acta 172:20–27. Scholar
  23. Cummings J, Lee G, Ritter A, Zhong K (2018) Alzheimer’s disease drug development pipeline: 2018. Alzheimers Dement (New York, N Y) 4:195–214. Scholar
  24. Dekker AD, Fortea J, Blesa R, De Deyn PP (2017) Cerebrospinal fluid biomarkers for Alzheimer’s disease in down syndrome. Alzheimers Dement (Amsterdam, Netherlands) 8:1–10. Scholar
  25. Dong H, Zhang L, Liu W, Tian Y (2017) Label-free electrochemical biosensor for monitoring of chloride ion in an animal model of Alzhemier’s disease. ACS Chem Neurosci 8(2):339–346. Scholar
  26. Dubois B, Picard G, Sarazin M (2009) Early detection of Alzheimer’s disease: new diagnostic criteria. Dialogues Clin Neurosci 11(2):135–139PubMedPubMedCentralGoogle Scholar
  27. Dubois B, Padovani A, Scheltens P, Rossi A, Dell’Agnello G (2015) Timely diagnosis for Alzheimer’s disease: a literature review on benefits and challenges. J Alzheimers Dis 49(3):617–631. Scholar
  28. Erdem A, Eksin E, Congur G (2015) Indicator-free electrochemical biosensor for microRNA detection based on carbon nanofibers modified screen printed electrodes. J Electroanal Chem 755:167–173. Scholar
  29. Fonseca-Santos B, Gremião MPD, Chorilli M (2015) Nanotechnology-based drug delivery systems for the treatment of Alzheimer’s disease. Int J Nanomedicine 10:4981–5003. Scholar
  30. Frisoni GB, Boccardi M, Barkhof F, Blennow K, Cappa S, Chiotis K, Démonet J-F, Garibotto V, Giannakopoulos P, Gietl A, Hansson O, Herholz K, Jack CR Jr, Nobili F, Nordberg A, Snyder HM, Ten Kate M, Varrone A, Albanese E, Becker S, Bossuyt P, Carrillo MC, Cerami C, Dubois B, Gallo V, Giacobini E, Gold G, Hurst S, Lönneborg A, Lovblad K-O, Mattsson N, Molinuevo J-L, Monsch AU, Mosimann U, Padovani A, Picco A, Porteri C, Ratib O, Saint-Aubert L, Scerri C, Scheltens P, Schott JM, Sonni I, Teipel S, Vineis P, Visser PJ, Yasui Y, Winblad B (2017) Strategic roadmap for an early diagnosis of Alzheimer’s disease based on biomarkers. Lancet Neurol 16(8):661–676. Scholar
  31. Fukumoto H, Tennis M, Locascio JJ, Hyman BT, Growdon JH, Irizarry MC (2003) Age but not diagnosis is the main predictor of plasma amyloid β-protein levels. Arch Neurol 60(7):958–964. Scholar
  32. Ghanbari H, Ghanbari K, Beheshti I, Munzar M, Vasauskas A, Averback P (1998) Biochemical assay for AD7C-NTP in urine as an Alzheimer’s disease marker. J Clin Lab Anal 12(5):285–288.<285::AID-JCLA6>3.0.CO;2-5CrossRefPubMedGoogle Scholar
  33. Hajipour MJ, Santoso MR, Rezaee F, Aghaverdi H, Mahmoudi M, Perry G (2017) Advances in Alzheimer’s diagnosis and therapy: the implications of nanotechnology. Trends Biotechnol 35(10):937–953. Scholar
  34. Hansen N (2014) Brain stimulation for combating Alzheimer’s disease. Front Neurol 5:80–80. Scholar
  35. Hardy J (2009) The amyloid hypothesis for Alzheimer’s disease: a critical reappraisal. J Neurochem 110(4):1129–1134. Scholar
  36. Hock C, Heese K, Müller-Spahn F, Huber P, Riesen W, Nitsch RM, Otten U (2000) Increased CSF levels of nerve growth factor in patients with Alzheimer’s disease. Neurology 54(10):2009. Scholar
  37. Houmani N, Vialatte F, Gallego-Jutglà E, Dreyfus G, Nguyen-Michel V-H, Mariani J, Kinugawa K (2018) Diagnosis of Alzheimer’s disease with electroencephalography in a differential framework. PLoS One 13(3):e0193607. Scholar
  38. Huang Y, Mucke L (2012) Alzheimer mechanisms and therapeutic strategies. Cell 148(6):1204–1222. Scholar
  39. Humpel C (2011) Identifying and validating biomarkers for Alzheimer’s disease. Trends Biotechnol 29(1):26–32. Scholar
  40. Hye A, Lynham S, Thambisetty M, Causevic M, Campbell J, Byers HL, Hooper C, Rijsdijk F, Tabrizi SJ, Banner S, Shaw CE, Foy C, Poppe M, Archer N, Hamilton G, Powell J, Brown RG, Sham P, Ward M, Lovestone S (2006) Proteome-based plasma biomarkers for Alzheimer’s disease. Brain 129(11):3042–3050. Scholar
  41. Iqbal K, Liu F, Gong C-X (2015) Tau and neurodegenerative disease: the story so far. Nat Rev Neurol 12:15. Scholar
  42. Isaac MT, Vamvakas S, Isaac MB (2017) Diagnostic biomarkers for Alzheimer’s disease: a regulatory view. Lancet Neurol 16(8):580–581. Scholar
  43. Isin D, Eksin E, Erdem A (2017) Graphene oxide modified single-use electrodes and their application for voltammetric miRNA analysis. Mater Sci Eng C 75:1242–1249. Scholar
  44. Jain KK (2005) The role of nanobiotechnology in drug discovery. Drug Discov Today 10(21):1435–1442. Scholar
  45. Jalonen TO, Charniga CJ, Wielt DB (1997) β-Amyloid peptide-induced morphological changes coincide with increased K+ and Cl− channel activity in rat cortical astrocytes. Brain Res 746(1):85–97. Scholar
  46. Jellinger KA, Janetzky B, Attems J, Kienzl E (2008) Biomarkers for early diagnosis of Alzheimer disease: ‘ALZheimer ASsociated gene’–a new blood biomarker? J Cell Mol Med 12(4):1094–1117. Scholar
  47. Khare P, Talreja N, Deva D, Sharma A, Verma N (2013) Carbon nanofibers containing metal-doped porous carbon beads for environmental remediation applications. Chem Eng J 229:72–81. Scholar
  48. Kim H, Lee JU, Song S, Kim S, Sim SJ (2018) A shape-code nanoplasmonic biosensor for multiplex detection of Alzheimer’s disease biomarkers. Biosen Bioelectron 101:96–102. Scholar
  49. Kumar D, Talreja N (2018) Nickel nanoparticles-doped rhodamine grafted carbon nanofibers as colorimetric probe: naked eye detection and highly sensitive measurement of aqueous Cr3+ and Pb2+. Korean J Chem Eng. Scholar
  50. Kumar V, Talreja N, Deva D, Sankararamakrishnan N, Sharma A, Verma N (2011) Development of bi-metal doped micro- and nano multi-functional polymeric adsorbents for the removal of fluoride and arsenic(V) from wastewater. Desalination 282:27–38. Scholar
  51. Kumar P, Dezso Z, MacKenzie C, Oestreicher J, Agoulnik S, Byrne M, Bernier F, Yanagimachi M, Aoshima K, Oda Y (2013) Circulating miRNA biomarkers for Alzheimer’s disease. PLoS One 8(7):e69807. Scholar
  52. Kumar A, Singh A, Ekavali SA (2015) A review on Alzheimer’s disease pathophysiology and its management: an update. Pharmacol Rep 67(2):195–203. Scholar
  53. Kumar R, Ashfaq M, Verma N (2018) Synthesis of novel PVA–starch formulation-supported Cu–Zn nanoparticle carrying carbon nanofibers as a nanofertilizer: controlled release of micronutrients. J Mater Sci 53(10):7150–7164. Scholar
  54. Kuo Y-M, Kokjohn TA, Kalback W, Luehrs D, Galasko DR, Chevallier N, Koo EH, Emmerling MR, Roher AE (2000) Amyloid-β peptides interact with plasma proteins and erythrocytes: implications for their quantitation in plasma. Biochem Biophys Res Commun 268(3):750–756. Scholar
  55. Kurz A, Perneczky R (2011) Novel insights for the treatment of Alzheimer’s disease. Prog Neuro-Psychopharmacol Biol Psychiatry 35(2):373–379. Scholar
  56. Lashley T, Schott JM, Weston P, Murray CE, Wellington H, Keshavan A, Foti SC, Foiani M, Toombs J, Rohrer JD, Heslegrave A, Zetterberg H (2018) Molecular biomarkers of Alzheimer’s disease: progress and prospects. Disease Models & Mechanisms 11(5):dmm031781. Scholar
  57. Levy S, McConville M, Lazaro GA, Averback P (2007) Competitive ELISA studies of neural thread protein in urine in Alzheimer’s disease. J Clin Lab Anal 21(1):24–33. Scholar
  58. Li S-S, Lin C-W, Wei K-C, Huang C-Y, Hsu P-H, Liu H-L, Lu Y-J, Lin S-C, Yang H-W, Ma C-CM (2016) Non-invasive screening for early Alzheimer’s disease diagnosis by a sensitively immunomagnetic biosensor. Sci Rep 6:25155. Scholar
  59. Lista S, Faltraco F, Prvulovic D, Hampel H (2013) Blood and plasma-based proteomic biomarker research in Alzheimer’s disease. Prog Neurobiol 101–102:1–17. Scholar
  60. Mantzavinos V, Alexiou A (2017) Biomarkers for Alzheimer’s disease diagnosis. Curr Alzheimer Res 14(11):1149–1154. Scholar
  61. Mohan VB, Lau K-T, Hui D, Bhattacharyya D (2018) Graphene-based materials and their composites: a review on production, applications and product limitations. Compos Part B Eng 142:200–220. Scholar
  62. Munzar M, Levy S, Rush R, Averback P (2002) Clinical study of a urinary competitve ELISA for neural thread protein in Alzheimer disease. Neurol Clin Neurophysiol 2002(1):2–8. Scholar
  63. Nag A, Mitra A, Mukhopadhyay SC (2018) Graphene and its sensor-based applications: a review. Sens Actuators A Phys 270:177–194. Scholar
  64. Nobile S, Nobile L (2017) Nanotechnology for biomedical applications: recent advances in neurosciences and bone tissue engineering. Polym Eng Sci 57(7):644–650. Scholar
  65. Olson L, Humpel C (2010) Growth factors and cytokines/chemokines as surrogate biomarkers in cerebrospinal fluid and blood for diagnosing Alzheimer’s disease and mild cognitive impairment. Exp Gerontol 45(1):41–46. Scholar
  66. Omar RA, Afreen S, Talreja N, Chauhan D, Ashfaq M (2019) Impact of nanomaterials in plant systems, in plant nanobionics: volume 1. In Prasad R (ed) Advances in the understanding of nanomaterials research and applications. Springer International Publishing, Cham, pp 117–140CrossRefGoogle Scholar
  67. Ovais M, Zia N, Ahmad I, Khalil AT, Raza A, Ayaz M, Sadiq A, Ullah F, Shinwari ZK (2018) Phyto-therapeutic and Nanomedicinal approaches to cure Alzheimer’s disease: present status and future opportunities. Front Aging Neurosci 10(284).
  68. Prabhulkar S, Piatyszek R, Cirrito JR, Wu Z-Z, Li C-Z (2012) Microbiosensor for Alzheimer’s disease diagnostics: detection of amyloid beta biomarkers. J Neurochem 122(2):374–381. Scholar
  69. Rees M, Moghimi SM (2012) Nanotechnology: from fundamental concepts to clinical applications for healthy aging. Maturitas 73(1):1–4. Scholar
  70. Ren S, Rong P, Yu Q (2018) Preparations, properties and applications of graphene in functional devices: a concise review. Ceram Int 44(11):11940–11955. Scholar
  71. Ringman JM, Liang L-J, Zhou Y, Vangala S, Teng E, Kremen S, Wharton D, Goate A, Marcus DS, Farlow M, Ghetti B, McDade E, Masters CL, Mayeux RP, Rossor M, Salloway S, Schofield PR, Cummings JL, Buckles V, Bateman R, Morris JC, Dominantly Inherited Alzheimer N (2015) Early behavioural changes in familial Alzheimer’s disease in the dominantly inherited Alzheimer network. Brain J Neurol 138(Pt 4):1036–1045. Scholar
  72. Sabbagh MN, Lue L-F, Fayard D, Shi J (2017) Increasing precision of clinical diagnosis of Alzheimer’s disease using a combined algorithm incorporating clinical and novel biomarker data. Neurol Ther 6(Suppl 1):83–95. Scholar
  73. Sahoo SK, Parveen S, Panda JJ (2007) The present and future of nanotechnology in human health care. Nanomed Nanotechnol Biol Med 3(1):20–31. Scholar
  74. Sangubotla R, Kim J (2018) Recent trends in analytical approaches for detecting neurotransmitters in Alzheimer’s disease. TrAC Trends in Analytical Chemistry 105:240–250. Scholar
  75. Sankararamakrishnan N, Chauhan D, Dwivedi J (2016) Synthesis of functionalized carbon nanotubes by floating catalytic chemical vapor deposition method and their sorption behavior toward arsenic. Chem Eng J 284:599–608. Scholar
  76. Saraswat R, Talreja N, Deva D, Sankararamakrishnan N, Sharma A, Verma N (2012) Development of novel in situ nickel-doped, phenolic resin-based micro–nano-activated carbon adsorbents for the removal of vitamin B-12. Chem Eng J 197:250–260. Scholar
  77. Seo DH, Pineda S, Fang J, Gozukara Y, Yick S, Bendavid A, Lam SKH, Murdock AT, Murphy AB, Han ZJ, Ostrikov K (2017) Single-step ambient-air synthesis of graphene from renewable precursors as electrochemical genosensor. Nat Commun 8:14217. Scholar
  78. Sharma N, Singh AN (2016) Exploring biomarkers for Alzheimer’s disease. J Clin Diagn Res 10(7):KE01–KE06. Scholar
  79. Sharma AK, Khare P, Singh JK, Verma N (2013) Preparation of novel carbon microfiber/carbon nanofiber-dispersed polyvinyl alcohol-based nanocomposite material for lithium-ion electrolyte battery separator. Mater Sci Eng C 33(3):1702–1709. Scholar
  80. Shi J, Fang Y (2018) 9 – biomedical applications of graphene. In: Zhu H, Xu Z, Xie D, Fang Y (eds) Graphene. Academic, pp 215–232. Scholar
  81. Singh S, Ashfaq M, Singh RK, Joshi HC, Srivastava A, Sharma A, Verma N (2013) Preparation of surfactant-mediated silver and copper nanoparticles dispersed in hierarchical carbon micro-nanofibers for antibacterial applications. New Biotechnol 30(6):656–665. Scholar
  82. Singh S, Modi A, Verma N (2016) Enhanced power generation using a novel polymer-coated nanoparticles dispersed-carbon micro-nanofibers-based air-cathode in a membrane-less single chamber microbial fuel cell. Int J Hydrogen Energy 41(2):1237–1247. Scholar
  83. Talreja N, Kumar D, Verma N (2014) Removal of hexavalent chromium from water using Fe-grown carbon nanofibers containing porous carbon microbeads. J Water Process Eng 3:34–45. Scholar
  84. Talreja N, Verma N, Kumar D (2016) Carbon bead-supported ethylene Diamine-functionalized carbon nanofibers: an efficient adsorbent for salicylic acid. Clean (Weinh) 44(11):1461–1470. Scholar
  85. Thal DR, Griffin WST, Braak H (2008) Parenchymal and vascular Abeta-deposition and its effects on the degeneration of neurons and cognition in Alzheimer’s disease. J Cell Mol Med 12(5B):1848–1862. Scholar
  86. Thambisetty M, Lovestone S (2010) Blood-based biomarkers of Alzheimer’s disease: challenging but feasible. Biomark Med 4(1):65–79. Scholar
  87. Thambisetty M, Simmons A, Hye A, Campbell J, Westman E, Zhang Y, Wahlund L-O, Kinsey A, Causevic M, Killick R, Kloszewska I, Mecocci P, Soininen H, Tsolaki M, Vellas B, Spenger C, Lovestone S, for the AddNeuroMed c (2011) Plasma biomarkers of brain atrophy in Alzheimer’s disease. PLoS One 6(12):e28527. Scholar
  88. Toivari E, Manninen T, Nahata AK, Jalonen TO, Linne M-L (2011) Effects of transmitters and amyloid-beta peptide on calcium signals in rat cortical astrocytes: Fura-2AM measurements and stochastic model simulations. PLoS One 6(3):e17914–e17914. Scholar
  89. Tuppo EE, Forman LJ, Spur BW, Chan-Ting RE, Chopra A, Cavalieri TA (2001) Sign of lipid peroxidation as measured in the urine of patients with probable Alzheimer’s disease. Brain Res Bull 54(5):565–568. Scholar
  90. Vestergaard M, Kerman K, Saito M, Nagatani N, Takamura Y, Tamiya E (2005) A rapid label-free electrochemical detection and kinetic study of Alzheimer’s amyloid Beta aggregation. J Am Chem Soc 127(34):11892–11893. Scholar
  91. Vilela P, El-Sagheer A, Millar TM, Brown T, Muskens OL, Kanaras AG (2017) Graphene oxide-Upconversion nanoparticle based optical sensors for targeted detection of mRNA biomarkers present in Alzheimer’s disease and prostate cancer. ACS Sens 2(1):52–56. Scholar
  92. Weller J, Budson A (2018) Current understanding of Alzheimer’s disease diagnosis and treatment [version 1; referees: 2 approved]. F1000Research 7(1161). Scholar
  93. Yadav A, Faisal M, Subramaniam A, Verma N (2017) Nickel nanoparticle-doped and steam-modified multiscale structure of carbon micro-nanofibers for hydrogen storage: effects of metal, surface texture and operating conditions. Int J Hydrogen Energy 42(9):6104–6117. Scholar
  94. Yiannopoulou KG, Papageorgiou SG (2013) Current and future treatments for Alzheimer’s disease. Ther Adv Neurol Disord 6(1):19–33. Scholar
  95. Zäch M, Hägglund C, Chakarov D, Kasemo B (2006) Nanoscience and nanotechnology for advanced energy systems. Curr Opin Solid State Mater Sci 10(3):132–143. Scholar
  96. Zhao Y, Tan W, Sheng W, Li X (2015) Identification of biomarkers Associated with Alzheimer’s disease by bioinformatics analysis. Am J Alzheimers Dis Other Dement 31(2):163–168. Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  • Mohammad Ashfaq
    • 1
    • 2
    • 3
    Email author
  • Neetu Talreja
    • 4
  • Divya Chuahan
    • 5
  • Werayut Srituravanich
    • 2
    • 3
  1. 1.School of Life ScienceBS Abdur Rahaman Crescent Institute of Science and TechnologyChennaiIndia
  2. 2.Department of Mechanical Engineering, Faculty of EngineeringChulalongkorn UniversityBangkokThailand
  3. 3.Biomedical Engineering Research Center, Faculty of EngineeringChulalongkorn UniversityBangkokThailand
  4. 4.Department of Bio-nanotechnologyGachon UniversitySeongnamSouth Korea
  5. 5.Department of ChemistryPunjab UniversityChandigarhIndia

Personalised recommendations